{"id":"https://openalex.org/W2563972273","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","title":"Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP).","display_name":"Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP).","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2563972273","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","mag":"2563972273"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.4666","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021183845","display_name":"Ana M. Aparicio","orcid":"https://orcid.org/0000-0003-0900-0923","observed_orcids":["https://orcid.org/0000-0003-0900-0923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Aparicio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066372195","display_name":"Andrea Lynne Harzstark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. L. Harzstark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"E. Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062740919","display_name":"Paul Gettys Corn","orcid":"https://orcid.org/0000-0002-4106-6335","observed_orcids":["https://orcid.org/0000-0002-4106-6335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. G. Corn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048915309","display_name":"John C. Araujo","orcid":"https://orcid.org/0000-0001-9361-3364","observed_orcids":["https://orcid.org/0000-0001-9361-3364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. C. Araujo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009388082","display_name":"Shi\u2010Ming Tu","orcid":"https://orcid.org/0000-0003-0015-2111","observed_orcids":["https://orcid.org/0000-0003-0015-2111"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Tu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"L. C. Pagliaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. C. Pagliaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081674746","display_name":"Randal E. Millikan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. E. Millikan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042976999","display_name":"Wadih Arap","orcid":"https://orcid.org/0000-0002-8686-4584","observed_orcids":["https://orcid.org/0000-0002-8686-4584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Arap","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032762979","display_name":"J. Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012804612","display_name":"Charles J. Ryan","orcid":"https://orcid.org/0000-0002-2081-3557","observed_orcids":["https://orcid.org/0000-0002-2081-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. J. Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059272502","display_name":"Amado J. Zurita","orcid":"https://orcid.org/0000-0002-3805-7307","observed_orcids":["https://orcid.org/0000-0002-3805-7307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. J. Zurita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. M. Tannir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024203592","display_name":"Amy Lin","orcid":"https://orcid.org/0000-0001-7757-6719","observed_orcids":["https://orcid.org/0000-0001-7757-6719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. M. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. J. Small","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063763615","display_name":"Paul F. Mathew","orcid":"https://orcid.org/0000-0002-4162-8908","observed_orcids":["https://orcid.org/0000-0002-4162-8908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Mathew","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102192012","display_name":"DONNAH M. JONES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. M. Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024553298","display_name":"P. Troncoso","orcid":"https://orcid.org/0000-0003-3695-6031","observed_orcids":["https://orcid.org/0000-0003-3695-6031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Troncoso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002347804","display_name":"Peter F. Thall","orcid":"https://orcid.org/0000-0002-7293-529X","observed_orcids":["https://orcid.org/0000-0002-7293-529X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. F. Thall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071719212","display_name":"C. Logothetis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Logothetis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"4666","last_page":"4666"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-prostate-cancer","display_name":"small cell prostate cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.527999997138977},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.546999990940094},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8650000095367432},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.33799999952316284},{"id":"https://openalex.org/keywords/ar-splice-variants","display_name":"androgen receptor splice variants","score":0.4729999899864197},{"id":"https://openalex.org/keywords/androgen-receptor-splice-variant-7","display_name":"androgen receptor splice variant 7","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8657535910606384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.846084713935852},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6126399040222168},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6109726428985596},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5969818830490112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5938241481781006},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5348182320594788},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4820469319820404},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4450720548629761},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4371917247772217},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3755807876586914},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34464675188064575}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.4666","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.4666","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2589520362","https://openalex.org/W2106315111","https://openalex.org/W2472967673","https://openalex.org/W2077426390","https://openalex.org/W2052620947","https://openalex.org/W2236157811","https://openalex.org/W2015624466","https://openalex.org/W3162243928","https://openalex.org/W2050618702","https://openalex.org/W4390731739"],"abstract_inverted_index":{"4666":[0],"Background:":[1],"Small":[2],"cell":[3],"prostate":[4],"cancer":[5],"(SCPC)":[6],"predicts":[7],"for":[8,92,234],"resistance":[9],"to":[10,15,41,76,89,174,222,237,318],"androgen":[11,319],"ablation,":[12],"frequent":[13],"response":[14,79],"platinum-based":[16],"chemotherapy,":[17],"but":[18,33],"short":[19],"survival.":[20],"We":[21,216],"hypothesize":[22],"that":[23,203],"PCa":[24,50,87,209,225,248,260],"patients":[25,84,245],"who":[26],"share":[27,37],"clinical":[28,81,214,232],"features":[29,257],"with":[30,48,54,85,246,264],"SCPC":[31,274],"(Table)":[32,51],"are":[34],"morphologically":[35],"heterogeneous":[36],"its":[38],"high":[39],"responsiveness":[40],"chemotherapy":[42],"and":[43,59,71,80,88,134,140,147,156,165,182,253],"underlying":[44,240],"biology.":[45,241],"Methods:":[46],"Men":[47],"anaplastic":[49,219,247,259],"were":[52,104],"treated":[53,254],"frontline":[55],"CD":[56,177],"(C:AUC":[57],"5":[58,284],"D:75mg/m2":[60],"Q21days)":[61,75],"followed,":[62],"at":[63,115,121,265],"disease":[64],"progression":[65],"(PD),":[66],"by":[67,213],"salvage":[68],"EP":[69,160,184],"(E:120mg/m2/day":[70],"C:25mg/m2/day":[72],"x":[73],"3":[74],"determine":[77],"the":[78,201,218,231,235,239,269],"course":[82],"of":[83,101,143,152,159,162,170,207,224,258,268,273],"\u201canaplastic\u201d":[86],"assemble":[90],"tissues":[91],"biological":[93],"interrogation.":[94],"Results:":[95],"Preliminary":[96],"data":[97],"analysis":[98],"shows":[99],"115":[100],"121":[102],"registered":[103],"eligible.":[105],"Six":[106],"(5%)":[107],"had":[108],"primary":[109],"SCPC.":[110],"Median":[111,172,189],"(range)":[112],"Gleason":[113],"score":[114],"diagnosis":[116,127],"was":[117],"9":[118],"(5-10),":[119],"age":[120],"registration":[122],"64":[123],"(39-80),":[124],"time":[125,173],"from":[126],"1":[128],"(0-20)":[129],"years,":[130],"PSA":[131,290],"7ng/mL":[132],"(0-925)":[133],"follow-up":[135],"11.9":[136],"months.":[137,188,196],"After":[138,154],"2":[139,155],"4":[141,157],"cycles":[142,158],"CD,":[144],"96":[145],"(83.5%)":[146],"76":[148],"(66.1%)":[149],"remained":[150,168],"free":[151,169],"PD.":[153,171],"45":[161],"71":[163],"(63.4%)":[164],"31":[166],"(43.7%)":[167],"PD":[175],"after":[176,183],"is":[178,192],"5.1":[179],"(95%CI:":[180,186,194],"4.11-6.12)":[181],"2.92":[185],"1.58-3.32)":[187],"overall":[190],"survival":[191],"15.36":[193],"13.39-19.01)":[195],"Conclusions:":[197],"Our":[198],"observations":[199],"support":[200],"hypothesis":[202],"a":[204],"distinct":[205],"variant":[206],"lethal":[208],"can":[210],"be":[211,250],"identified":[212],"features.":[215],"estimate":[217],"Pca":[220],"contribute":[221],"30%":[223],"deaths.":[226],"These":[227],"findings":[228],"serve":[229],"as":[230],"foundation":[233],"efforts":[236],"understand":[238],"If":[242],"prospectively":[243],"confirmed":[244],"must":[249],"recognized":[251],"early":[252],"aggressively.":[255],"Clinical":[256],"(eligibility":[261],"criteria).":[262],"CRPC":[263],"least":[266],"one":[267],"following:":[270],"Histologic":[271],"evidence":[272],"Exclusively":[275],"visceral":[276],"metastases":[277,281,298],"Predominantly":[278],"lytic":[279],"bone":[280,297],"Bulky":[282],"(\u2265":[283],"cm)":[285],"lymphadenopathy":[286],"or":[287,304,306,309,314],"pelvic/prostate":[288],"mass":[289],"\u2264":[291,322],"10":[292],"ng/mL":[293],"plus":[294,311],"\u2265":[295],"20":[296],"Neuroendocrine":[299],"markers":[300],"on":[301],"histology":[302],"(ChrA":[303,308],"Syn)":[305],"serum":[307],"GRP)":[310],"LDH\u22652xULN,":[312],"CEA\u22652xULN":[313],"malignant":[315],"hypercalcemia":[316],"Response":[317],"deprivation":[320],"therapy":[321],"6":[323],"months":[324]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2017-01-06T00:00:00"}